New Federal Contractors — June 17, 2026

The $309.6 million firm-fixed-price delivery order from the Maritime Administration is 85% funded ($264.2M outlayed), reducing future payment risk and providing multi-year revenue visibility through August 2029.

The cost-plus-fixed-fee structure for the $126.4M NIH NCI GOCO facility contract limits margin upside but provides low-risk, stable revenue through August 2024, with $74.2M already outlayed.

The firm-fixed-price structure for the Yosemite wastewater treatment plant replacement transfers cost overrun risk to Kiewit, with a 5.5-year performance period and no options, potentially compressing margins on a complex construction project.

Kiewit Infrastructure West's $103.3M firm-fixed-price contract for a complex wastewater treatment plant replacement in Yosemite carries high cost overrun risk over a 5.5-year period, with no options to adjust pricing.

TOTE Services' $309.6M firm-fixed-price vessel delivery contract through 2029 carries fixed-price execution risk, though 85% funding reduces payment uncertainty.

Leidos Biomedical Research's $126.4M NIH NCI contract ends August 2024 with no options, creating a re-compete risk that could disrupt revenue if not renewed.

TOTE Services' $309.6M NSMV V contract positions the company for follow-on vessel construction awards from the Maritime Administration, given the fully funded, competitively won nature of the award.

Kiewit Infrastructure West's $103.3M NPS contract signals continued federal investment in national park infrastructure, potentially leading to additional wastewater or infrastructure replacement contracts across the park system.

Leidos Biomedical Research's $126.4M NIH NCI contract reinforces Leidos' position in federal life sciences R&D support, a stable civilian revenue stream that complements its defense portfolio.

Two of three contracts ($413M total) are civilian infrastructure or facility management awards, with TOTE Services ($309.6M) and Kiewit Infrastructure West ($103.3M) highlighting stable but execution-sensitive civilian spending.

All three contracts provide multi-year revenue streams (5-7 years), but the firm-fixed-price structures for TOTE and Kiewit introduce margin compression risk, while Leidos' cost-plus structure offers stability.

{"entity"=>"TOTE Services", "reason"=>"The $309.6M NSMV V contract is 85% funded but carries fixed-price execution risk through 2029.", "trigger"=>"Contract modifications, cost overrun disclosures, or follow-on NSMV awards from Maritime Administration"}

{"entity"=>"Kiewit Infrastructure West", "reason"=>"The $103.3M fixed-price Yosemite wastewater plant contract has high execution risk over 5.5 years.", "trigger"=>"Quarterly earnings reports for cost overrun mentions, National Park Service budget allocations"}

{"entity"=>"Leidos Holdings", "reason"=>"The $126.4M NIH NCI contract ends August 2024 with no options, creating re-compete risk.", "trigger"=>"Follow-on contract awards or extensions for GOCO facility management at Frederick"}